Carlos Jiménez to Mycophenolic Acid
This is a "connection" page, showing publications Carlos Jiménez has written about Mycophenolic Acid.
Connection Strength
0.941
-
Martin-Moreno PL, S?nchez-Fructuoso AI, Mazuecos A, Mir M, Lopez-Lopez I, Gonz?lez-Rinne A, Coca A, Valero R, Ventura Galiano A, Ridao N, Toapanta-Gaibor NG, Fern?ndez-Tagarro E, Cruzado-Vega L, P?rez-Mir M, Jim?nez C. Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study. Clin Transplant. 2021 05; 35(5):e14256.
Score: 0.688
-
L?pez-Oliva MO, P?rez-Flores I, Molina M, Jos? Aladr?n M, Trujillo H, Redondo-Pach?n D, L?pez V, Facundo C, Villanego F, Rodr?guez M, Carmen Ruiz M, Ant?n P, Rivas-Oural A, Cabello S, Portol?s J, de la Vara L, Tabernero G, Valero R, Galeano C, Moral E, Ventura A, Coca A, ?ngel Mu?oz M, Hern?ndez-Gallego R, Shabaka A, Ledesma G, Bouarich H, ?ngeles Rodr?guez M, P?rez Tamaj?n L, Cruzado L, Emilio S?nchez J, Jim?nez C. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry. Nefrologia (Engl Ed). 2023 Jul-Aug; 43(4):442-451.
Score: 0.205
-
Pascual J, Jim?nez C, Krajewska M, Seron D, Kotton CN, Portol?s J, Witzke O, Sorensen SS, Andr?s A, Crespo M, Paz-Artal E, D?ez T, Ortega A, Portero I. The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients. Transpl Immunol. 2022 12; 75:101711.
Score: 0.048